通心络对2型糖尿病肾病大鼠纤溶调节因子PAI-1表达的影响  被引量:3

Effects of Tongxinluo on PAI-1 level in rats with type 2 diabetic nephropathy

在线阅读下载全文

作  者:邹大威[1] 高彦彬[1] 李娇阳[1] 周盛楠[1] 张娜[1] 吴晓明[1] 田年秀 王晓磊[1] 朱智耀[1] 

机构地区:[1]首都医科大学中医药学院中医络病研究北京市重点实验室,北京100069

出  处:《环球中医药》2017年第12期1434-1437,共4页Global Traditional Chinese Medicine

基  金:国家重点基础研究发展计划(973计划)(2012CB518602);国家自然科学基金青年科学基金(81302951)

摘  要:目的观察通心络对2型糖尿病肾病大鼠血流变、纤溶调节因子表达的影响。方法采用高脂饲料联合小剂量链脲佐菌素建立2型DN大鼠模型,随机分为模型组和通心络组各10只,设立10只正常SD大鼠为空白组;予通心络干预16周后,大鼠腹主动脉取血,测定空腹血糖(fasting blood glucose,FBG)、血清尿素氮(urea nitrogen,BUN)、血清肌酐(serum creatinine,Scr)、全血黏度(高切、低切)、血浆黏度、血小板聚集率、血浆纤维蛋白原、组织型纤溶酶原激活剂(tissue plasminogenemia activator,t PA)及纤溶酶原激活剂抑制剂-1(plasminogen activator inhibitor-1,PAI-1)。结果与空白组比较,模型组大鼠FBG、BUN、Scr均明显升高(P<0.05);全血黏度(高切、低切)、血浆黏度、血小板聚集率、血浆纤维蛋白原及PAI-1明显升高,t-PA明显降低。与模型组比较,通心络组BUN、Scr均明显降低(P<0.05),高、低切变率下的全血黏度、血浆黏度、血浆纤维蛋白原含量、血小板聚集率及PAI-1水平明显降低(P<0.05),但对FBG、t PA水平没有明显的影响。结论通心络可保护2型糖尿病肾病大鼠肾功能、减轻肾脏病理损伤;抗凝、降纤改善肾脏局部微循环灌注可能是其延缓DN进展的作用机制。Objective To explore effects of Tongxinluo on hemorheology and PAI level in rats with type 2 diabetic nephropathy. Methods The rat model of type 2 diabetes mellitus was induced by injection of low-dose of streptozocin after having high-fat diet. Diabetic rats were randomly divided the model group (n= 10) arid the Tongxinluo group( n = 10). Normal SD rats (n = 10) were used as the control group. After intervention with Tongxinluo for 8 weeks, fasting blood glucose (FBG), serum creatinine (Scr), serum urea nitrogen (BUN), tissue plasminogen activator (t-PA), plasminogen activator inhibitor type-1 (PAI-1) and hemorheoiogy indexes were detected. Results Compared with control group, FBG, SCr, BUN, hemorheology indexes in the model group were significantly increased while the PAI-1 was decreased (P〈 0.05 ). Compared with model group, BUN and Scr were significantly decreased ( P 〈 0. 05 ) ,hemorheology indexes and PAI-1 levels were significantly decreased ( P〈0. 05), but the FBG and tPA level had no obvious influence. Conclusion TongXinLuo can protect renal function and alleviate renal pathological damage in type 2 diabetic nephropathy rats. Anticoagulation, defibringen and improving local microcirculation perfusion may be the mechanisms of delaying DN progression.

关 键 词:糖尿病肾病 通心络 纤溶 组织型纤溶酶原激活剂 纤溶酶原激活物抑制物-1 

分 类 号:R285.5[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象